insideKENT Magazine Issue 45 - December 2015 | Page 16

NEWS

ZIARCO CHOOSES DISCOVERY PARK AS BASE
FOR NEW DRUG DEVELOPMENT
A biotechnology company is close to getting initial
results of patient trials back for a range of new
therapies for inflammatory and allergic diseases
– with Discovery Park at the heart of its success.
Ziarco moved into Discovery Park, on the outskirts
of Sandwich, in April, after an expansion that has
seen the venture funded business grow from a
team of four to 12, with five staff added since
relocating from its previous Canterbury base. It
also calls on a number of external advisors when
required.
The company, which launched in 2012, has used
the space to continue developing drugs for the
treatment of inflammatory and dermatological
diseases such as atopic dermatitis and psoriasis.
Clinical trials are underway and initial data is
expected during 2016. The company aims to
com ]H